Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Gw Pharma ADR (GWPH)

151.94 -2.76 (-1.78%)

05-21 16:00

Open:

156.5

Pre. Close:

154.7

High:

160.545

Low:

149.89

Volume:

675,136

Market Cap:

4285M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

160.776 - 161.587

161.587 - 162.253

Low:

148.106 - 148.923

148.923 - 149.595

Close:

150.735 - 152.024

152.024 - 153.084

Technical analysis  (as of: 2018-05-21 4:29:52 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 187.52     One year: 219.02

Support:

Support1: 140.31    Support2: 127.80

Resistance:

Resistance1: 160.54    Resistance2: 187.52

Pivot:

144.99

Moving Averages:

MA(5): 151.05     MA(20): 142.74

MA(100): 128.70     MA(250): 117.31

MACD:

MACD(12,26): 6.58     Signal(12,26,9): 6.10

%K %D:

%K(14,3): 86.62     %D(3): 90.68

RSI:

RSI(14): 68.93

52-Week:

High: 160.545  Low: 92.65  Change(%): 40.9

Average Vol(K):

3-Month: 40263  10-Days 46665

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
GWPH has closed below upper band by 18.4%. Bollinger Bands are 18.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-17T04:56:08-04:00
NYC sees marijuana revenue stream

2018-05-08T20:26:08-04:00
GW Pharmaceuticals' (GWPH) CEO Justin Gover on Q2 2018 Results - Earnings Call Transcript

2018-05-08T16:09:34-04:00
GW Pharmaceuticals misses by $0.64, beats on revenue

2018-05-07T17:35:34-04:00
Notable earnings after Tuesday's close

2018-04-27T09:41:32-04:00
Alcohol Stocks Fighting To Stay Relevant In A Marijuana Stock Market?

2018-04-23T08:00:00-04:00
Your Daily Pharma Scoop: Abeona's ABO-202, Revance Update, Ionis/Biogen's New Collaboration

2018-04-23T07:41:40-04:00
Game Plan For The Week - Cramer's Mad Money (4/20/18)

2018-04-23T04:44:48-04:00
Biotech Analysis Central Pharma News: J&J Scraps Antibiotic Program, Novartis Siponimod, GW Pharma's Major Support By Panel

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

28.20

Shares Float (M)

28.20

% Held by Insiders

% Held by Institutions

Shares Short (K)

1545

Shares Short Prior Month (K)

3450

Stock Financials

EPS

-8.380

EPS Est. Current Year

-6.160

EPS Est. Next Year

-7.540

EPS Est. Next Quarter

-1.960

Forward EPS

-4.300

Book Value (p.s.)

6.650

PEG Ratio

0.26

Profit Margin

Operating Margin

-1349.60

Return on Assets (ttm)

-35.5

Return on Equity (ttm)

-40.3

Qtrly Rev. Growth

178.8

Gross Profit (p.s.)

0.345

Sales Per Share

EBITDA (p.s.)

-6.311

Qtrly Earnings Growth

Operating Cash Flow (M)

-177.20

Levered Free Cash Flow (M)

-148.74

atoplab.com

Valuation

P/E

-18.13

P/E Growth Ratio

-0.02

P/BV

22.85

P/S

6491982336.00

P/CF

-24.18

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.